Drug Information

Drug General Information
Drug ID
D0ZQ3Q
Former ID
DNC013659
Drug Name
1-(4-ethyl-2,5-dimethoxyphenyl)propan-2-amine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529336]
Formula
C13H21NO2
Canonical SMILES
CCC1=CC(=C(C=C1OC)CC(C)N)OC
InChI
1S/C13H21NO2/c1-5-10-7-13(16-4)11(6-9(2)14)8-12(10)15-3/h7-9H,5-6,14H2,1-4H3
InChIKey
HXJKWPGVENNMCC-UHFFFAOYSA-N
PubChem Compound ID
27402
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Inhibitor [529336]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 529336Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Ref 529336Bioorg Med Chem. 2008 Apr 15;16(8):4661-9. Epub 2008 Feb 14.The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.